February 2012 Drug Update Information - Pharmacy Benefits ...

More documents

Recommendations

Info

200 mg tablet, 100 count (NDC 63304-0521- -01) 50 mg/mL, 50 mL suspension (NDC 63304-0965-03) 50 mg/mL, 100 mL suspension (NDC 63304-0965-04) 100 mg/mL, 50 mL suspension (NDC 63304-0966-03) 100 mg/mL, 100 mL suspension (NDC 63304-0966-04) Reason for the Shortage Ranbaxy has an import ban on all solid medications including cefpodoxime. Aurobindo cannot provide a reason for the shortage. Pfizer has discontinued Vantin. Article Link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=793 Source: http://www.a ashp.org Diphenhydramine Hydrochlori ide for Injection January 24, 2012 Products Affected - Description Diphenhydramine injection, 50 mg/mL, Hospira 1 mL Carpuject syringe (NDC 00409-2290-31) Diphenhydramine injection, 50 mg/mL, Mylan Institutional 10 mL vial (NDC 67457-0124-10) Diphenhydramine injection, 50 mg/mL, West-Ward (formerly Baxter products) 1 mL vial (NDC 00641-0376-25) Reason for the Shortage West-Ward (formerly Baxter products) cannot provide a reason for the shortage. APP stated that the shortage was due to increased demand for the product. Mylan Institutional has diphenhydramine injection on shortage due to increased demand. The company is increasing production to try to meet this demand. Hospira discontinued d diphenhydramine iSecure syringes in 2011. Pfizer discontinued all Benadryl injection in 2005. IMS discontinued diphenhydramine injectionn in April 2008. Article Link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=845 Source: http://www.a ashp.org Fentanyl Injection January 24, 2012 Products Affected - Description Fentanyl Injection 50 mcg/mL, Hospira 10 mL ampules (NDC 00409-9093-36) - discontinued 2 mL Carpuject syringe (NDC 00409-1276-32) 2 mL ampule (NDC 00409-9093-32) 5 mL ampule (NDC 00409-9093-35) 20 mL ampule (NDC 00409-9093-38) 2 mL vial (NDC 00409-9094-22) 5 mL vial (NDC 00409-9094-25) 10 mL vial (NDC 00409-9094-28) 20 mL vial (NDC 00409-9094-31) 50 mL vial (NDC 00409-9094-61) Fentanyl Injection 50 mcg/mL, West-Ward (formerly Baxter products) 10 mL ampule (NDC 10019-0034-73) - discontinued 30 mL single-dose vial (NDC 10019-0036-82) - discontinued 2 mL ampule (NDC 10019-0038-67) 28
5 mL ampule (NDC 10019-0033-72) 20 mL ampule (NDC 10019-0035-74) 2 mL vial (NDC 10019-0037-27) 5 mL vial (NDC 10019-0037-30) 20 mL vial (NDC 10019-0037-25) 50 mL vial (NDC 10019-0037-83) Reason for the Shortage West-Ward acquired Baxter’s fentanyl injection productss in May, 2011. The company cannot provide a reason for the shortage. Hospira states the shortage is due to increased demand and manufacturing delays including quality improvement activities. Hospira is ncreasing production of the ampules to help meet the demand. Article Link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=647 Source: http://www.a ashp.org Hydromorphone Hydrochloride Low Potency Injection January 24, 2012 Products Affected - Description Hydromorphone Injection, Hospira 1 mg/mL, 1 mL Carpuject syringes (NDC 00409-1283-31) 1 mg/mL, 1 mL ampules (NDC 00409-2552- -01) 2 mg/mL, 1 mL Carpuject syringes (NDC 00409-1312-30) 2 mg/mL, 1 mL iSecure syringess (NDC 00409-1312-10) 2 mg/mL, 1 mL ampules (NDC 00409-3356- -01) 2 mg/mL, 1 mL vials (NDC 00409-3365-01) 4 mg/mL, 1 mL Carpuject syringes (NDC 00409-1304-31) Hydromorphone Injection, West-Ward 2 mg/mL, 1 mL vials (NDC 00641-0121-25) Dilaudid Injection, Purdue 2 mg/mL, 1 mL ampules, package of 10 (NDC 59011-0442-10) 2 mg/mL, 1 mL ampules, package of 25 (NDC 59011-0442-25) Reason for the Shortage Hospira has hydromorphone injection on shortage due too manufacturing delays. West-Ward could not provide a reason for the shortage. Purdue could not provide a reason for the shortage. High potency hydromorphone injection (10 mg/mL) is not affected by this shortage. Article Link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=856 Source: http://www.a ashp.org Promethazine Injection January 24, 2012 Products Affected - Description Promethazine injection, West-Ward 25 mg/mL 1 mL dosette ampule (NDC 00641-1495-35) 25 mg/mL 1 mL vial (NDC 00641-0928-25) 50 mg/mL 1 mL vial (NDC 00641-0929-25) 50 mg/mL 1 mL Novaplus vial (NDC 00641-0956-25) Phenergan injection, West-Ward 25 mg/mL 1 mL ampule (NDC 60977-0001- -01) 25 mg/mL 1 mL vial (NDC 00641-6084-25) 29
Page 1 and 2: February 2012 Drug Information Upda
Page 3 and 4: GENERIC DRUG NAME GENERIC APPROVAL
Page 5 and 6: CICLOPIROX/ TOPICAL PEDIPIROX-4 New
Page 7 and 8: [Posted 01/09/2012] ISSUE: Novartis
Page 9 and 10: Studies Article Link: http://www.fd
Page 11 and 12: the use of XARELTO® (rivaroxaban),
Page 13 and 14: acteria. The Food and Drug Administ
Page 15 and 16: Statins raise risk of Type 2 diabet
Page 17 and 18: The Million Women Study, a U.K. pro
Page 19 and 20: Azithromycin 250 mg tablets, 1 card
Page 21 and 22: RECALLING FIRM/MANUFACTURE Recallin
Page 23 and 24: Recalling Firm: Pfizer Us Pharmaceu
Page 25 and 26: 250 mg, 100 count (NDC 00591-3969-0
Page 27: Sandoz states the shortage is due t
Page 31 and 32: Article Link: http://www.ashp.org/D
Page 33 and 34: Lidocaine 2% (with epinephrine 1:10
Page 35 and 36: Source: http://www.a ashp.org Halop
Page 37 and 38: ecome unavailable for an extended t
Page 39 and 40: American Regent resumed manufacturi
Page 41 and 42: Trandate tablets, Prometheus 100 mg
Page 43 and 44: Article link: http://www.ashp.org/D
Page 45 and 46: Bedford Laboratories has multiple p
Page 47 and 48: Thiothixene capsules, Mylan 2 mg ca
Page 49 and 50: 20 mL vials (NDC 10019-0905-03) - d
Page 51 and 52: 500 mg extended release, 500 count
Page 53 and 54: 1 mg/mL, 4 mL vial (NDC 25021-0781-
Page 55 and 56: West-Ward states the shortage is du
Page 57 and 58: 150 mL bottle (NDC 63304-0954-02) C

February 2012 Drug Update Information - Pharmacy Benefits ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?